Professional Documents
Culture Documents
Hospital
Department of Pharmacy Practice
Date:
Pharmacokinetics Parameters:
ADME: Low systemic bioavailability is due to pre-systemic clearance by
gastrointestinal mucosa and first-pass metabolism in the liver, distribution is 381 L,
metabolized to ortho - and para hydroxylated derivatives and various beta-oxidation
products. Eliminated primarily in bile after hepatic and / or extra hepatic metabolism.
Protein binding: >98% bound to plasma proteins.
t1/2: 14 hours
Peak plasma levels:
Pharmacodynamics Parameters:
Uses with dose: Given against heart disease and dosage of not more than once
every 2 to 4 weeks.
ADR: Myalgia, constipation, asthenia, abdominal pain, nausea and hepatotoxicity.
Drug interactions: Increased risk of rhadbomyolysis
Special conditions:
Pregnancy/Breast feeding: Contraindicated in pregnant women, and during breast
feeding.
Geriatric: --Paediatric: --Liver impairment: Should be prevented in case of liver disease
Kidney impairment: ---
Sign of student
Sign of faculty